Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Statsautoriseret fodterapeut Letpaafod ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.6% 6.2% 4.8% 5.6% 10.5% 10.9% 12.5% 12.3%   Credit score (0-100)   42 38 43 40 22 22 19 19   Credit rating   BBB BBB BBB BBB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   752 664 680 604 482 565 0.0 0.0   EBITDA   194 114 202 99.2 -85.5 23.9 0.0 0.0   EBIT   98.4 18.3 106 3.5 -168 -59.1 0.0 0.0   Pre-tax profit (PTP)   98.4 16.0 104.7 1.0 -168.6 -58.5 0.0 0.0   Net earnings   76.7 12.0 81.6 -0.7 -130.0 -45.7 0.0 0.0   Pre-tax profit without non-rec. items   98.4 16.0 105 1.0 -169 -58.5 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   38.5 25.5 12.7 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   816 773 798 740 551 445 327 327   Interest-bearing liabilities   5.7 2.5 2.0 2.7 5.1 1.1 0.0 0.0   Balance sheet total (assets)   1,080 1,034 1,005 948 683 555 327 327   Net Debt   -131 -244 -141 -296 -70.8 -201 -77.9 -77.9     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   752 664 680 604 482 565 0.0 0.0   Gross profit growth   3.9% -11.8% 2.5% -11.1% -20.2% 17.1% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,080 1,034 1,005 948 683 555 327 327   Balance sheet change%   2.9% -4.3% -2.8% -5.6% -27.9% -18.7% -41.1% 0.0%   Added value   194.3 114.3 201.9 99.2 -72.8 23.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -192 -192 -192 -191 -166 -166 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.1% 2.8% 15.6% 0.6% -34.9% -10.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.2% 1.7% 10.4% 0.4% -20.7% -9.4% 0.0% 0.0%   ROI %   10.2% 2.0% 11.7% 0.4% -23.4% -10.7% 0.0% 0.0%   ROE %   9.5% 1.5% 10.4% -0.1% -20.1% -9.2% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   75.9% 75.5% 79.7% 78.6% 81.4% 81.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -67.5% -213.6% -69.9% -298.6% 82.8% -841.1% 0.0% 0.0%   Gearing %   0.7% 0.3% 0.3% 0.4% 0.9% 0.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.3% 56.7% 57.1% 105.5% 2.2% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.6 2.1 2.1 3.0 2.0 3.6 0.0 0.0   Current Ratio   2.8 2.9 4.6 4.1 3.8 3.6 0.0 0.0   Cash and cash equivalent   136.8 246.8 143.2 298.8 75.9 202.4 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   218.0 252.0 353.5 369.2 223.3 186.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   194 114 202 99 -73 24 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   194 114 202 99 -85 24 0 0   EBIT / employee   98 18 106 3 -168 -59 0 0   Net earnings / employee   77 12 82 -1 -130 -46 0 0